Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 2

1(25.0%)

Phase 3

1(25.0%)

4Total

N/A(2)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT06074211Not ApplicableActive Not Recruiting

Incorporation of Safe Sleep Education Into m-Health Technology

Role: collaborator

NCT03321734Phase 2Completed

Intermittent Hypoxia and Caffeine in Infants Born Preterm

Role: collaborator

NCT01875159Phase 3Completed

Effects of Caffeine on Intermittent Hypoxia in Infants Born Preterm

Role: lead

NCT00482781Not ApplicableCompleted

DTaP and Apnea/Bradycardia in Preterm Infants

Role: lead

All 4 trials loaded